ImmunoPrecise (IPA) - Yalpi foyda normasi

ImmunoPrecise Antibodies (IPA) korporativ emblemasi va logotipi

ImmunoPrecise Antibodies (IPA) rivojlanishi B-hujayralarini skrining qilish uchun avtonom mikrofluidik tizimlarning joriy etilishi bilan ta'minlandi. Sotuv xarajatlari chegirilgandan keyingi yalpi foyda joriy dinamikani ko'rsatmoqda, bunda 47.20 ko'rsatkichi samaradorlikning joriy darajasini tasdiqlaydi. Kelajakka nazar tashlasak, muvaffaqiyat AI platformasining tijorat daromadiga va biofarmatsevtika buyurtmalarining foiz stavkalari tebranishlariga chidamliligiga bog'liq bo'lib, bu biznesning uzoq muddatli bahosini belgilaydi.

ImmunoPrecise Antibodies (IPA) Yalpi rentabellik: 04.07.2022 - 04.09.2025 davri uchun

ImmunoPrecise Antibodies (IPA) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
Fundamental baholash:immunoprecise.com, IPA
ImmunoPrecise yetakchi tovari

ImmunoPrecise Antibodies (IPA) kompaniyasining sog'liqni saqlash gigantlariga biotexnologik platformalar taqdim etishga asoslangan B2B modeli kompaniyaning bevosita xarajatlar tuzilmasini belgilaydi. Valo gross marjani tahlil qilish orqali investor ishlab chiqarish xarajatlaridan tozalangan daromad qismini ko'rishi mumkin, bu esa resurslarni boshqarish samaradorligini aks ettiradi. Ushbu gross marja ko'rsatkichi tendentsiyasi intellektual xizmatlarning yuqori narx belgilash imkoniyati va mahsulotlarni ishlab chiqishdagi kapital xarajatlar o'rtasidagi muvozanatni baholash imkonini beradi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik Pacific Biosciences PACB|Yalpi foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Yalpi marja|Rocket Pharmaceuticals - Yalpi foyda koeffitsiyenti|Sotuvning yalpi rentabelligi 4D Molecular Therapeutics, Inc.|Yalpi foyda marjasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Yalpi marja|Yalpi foyda marjasi Editas EDIT|Yalpi marja SLN|ProQR Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja CDXS (Codexis, Inc.)|SGMO: Sotuvning yalpi rentabelligi|Nautilus Biotechnology - Yalpi marja|Yalpi foyda normasi MGX (Metagenomi, Inc)|DTIL: Yalpi marja|GBIO: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Boundless Bio Inc.|Yalpi foyda bo'yicha rentabellik Exicure (XCUR)|Yalpi marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Yalpi foyda normasi|Mustang Bio, Inc. - Yalpi foyda bo'yicha rentabellik|RNAZ - Yalpi foyda bo'yicha rentabellik|BNGO: Yalpi foyda bo'yicha rentabellik|APDN (Applied DNA Sciences Inc) - Sotuvning yalpi rentabelligi|BLUE (Bluebird Bio) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik